CYTOMEGALOVIRUS PNEUMONITIS AFTER CARDIAC TRANSPLANTATION

被引:21
作者
SCHULMAN, LL
REISON, DS
AUSTIN, JHM
ROSE, EA
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT RADIOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV COLL PHYS & SURG, DEPT SURG, NEW YORK, NY 10032 USA
关键词
D O I
10.1001/archinte.151.6.1118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the incidence and clinical features of cytomegalovirus (CMV) pneumonitis after cardiac transplantation, we identified 27 (16%) of 171 consecutive recipients in whom CMV pneumonitis was confirmed by strict diagnostic criteria. Cytomegalovirus pneumonitis occurred in 6 (30%) of 20 patients treated with azathioprine and prednisone, and 8 (25%) of 32 patients treated with azathioprine, cyclosporine, and prednisone, but only 13 (11%) of 119 patients treated with cyclosporine and prednisone. The incidence of CMV pneumonitis was not related to recipient preoperative CMV titers or to postoperative cardiac rejection, but there was a trend toward increased CMV pneumonitis in patients who received organs from CMV-positive donors. Mean onset of CMV pneumonitis was 2.9 +/- 1.6 (SD) months after transplantation. In the azathioprine-prednisone group, CMV was always associated with at least one other respiratory pathogen (Aspergillus, n = 5; Pneumocystis carinii, n = 2). In the two cyclosporine groups, CMV was either the sole respiratory pathogen (n = 9), or associated with P carinii (n = 11). Roentgenographically, diffuse bilateral hazy pulmonary opacities were present in 19 (70%) of 27 patients, but focal subsegmental opacity (26%), small pleural effusion (26%), and lobar consolidation (7%) were also observed. When bronchoscopy was performed, bronchoalveolar lavage was the most sensitive technique for detecting CMV (72%), whereas transbronchial biopsy (39%) and combined washings and brushings (33%) were relatively insensitive techniques. Respiratory failure and death occurred in 52% and 44%, respectively, of patients with CMV pneumonitis. In this population of immunocompromised hosts: (1) CMV pneumonitis, alone or with other respiratory pathogens, was a major cause of morbidity and mortality; (2) localized roentgenographic opacity did not exclude CMV pneumonitis; (3) bronchoalveolar lavage was the most sensitive bronchoscopic technique for detecting CMV pneumonitis.
引用
收藏
页码:1118 / 1124
页数:7
相关论文
共 34 条
[1]   DIAGNOSIS OF CYTOMEGALOVIRUS PNEUMONIA IN COMPROMISED HOSTS [J].
ABDALLAH, PS ;
MARK, JBD ;
MERIGAN, TC .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (03) :326-332
[2]   PULMONARY INFECTION AFTER CARDIAC TRANSPLANTATION - CLINICAL AND RADIOLOGIC CORRELATIONS [J].
AUSTIN, JHM ;
SCHULMAN, LL ;
MASTROBATTISTA, JD .
RADIOLOGY, 1989, 172 (01) :259-265
[3]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[4]  
BESCHORNER WE, 1980, AM REV RESPIR DIS, V122, P107
[5]  
CORDONNIER C, 1985, AM REV RESPIR DIS, V132, P1118
[6]   RAPID DETECTION OF CYTOMEGALO-VIRUS PULMONARY INFECTION BY BRONCHOALVEOLAR LAVAGE AND CENTRIFUGATION CULTURE [J].
CRAWFORD, SW ;
BOWDEN, RA ;
HACKMAN, RC ;
GLEAVES, CA ;
MEYERS, JD ;
CLARK, JG .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :180-185
[7]   INTERSTITIAL LUNG-DISEASES OF UNKNOWN CAUSE .1. DISORDERS CHARACTERIZED BY CHRONIC INFLAMMATION OF THE LOWER RESPIRATORY-TRACT [J].
CRYSTAL, RG ;
BITTERMAN, PB ;
RENNARD, SI ;
HANCE, AJ ;
KEOGH, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) :154-166
[8]   MORBIDITY OF CYTOMEGALO-VIRUS INFECTION IN RECIPIENTS OF HEART OR HEART-LUNG TRANSPLANTS WHO RECEIVED CYCLOSPORINE [J].
DUMMER, JS ;
WHITE, LT ;
HO, M ;
GRIFFITH, BP ;
HARDESTY, RL ;
BAHNSON, HT .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1182-1191
[9]   EARLY INFECTIONS IN KIDNEY, HEART, AND LIVER-TRANSPLANT RECIPIENTS ON CYCLOSPORINE [J].
DUMMER, JS ;
HARDY, A ;
POORSATTAR, A ;
HO, M .
TRANSPLANTATION, 1983, 36 (03) :259-267
[10]   CYTOMEGALO-VIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION SUCCESSFULLY TREATED WITH THE COMBINATION OF GANCICLOVIR AND HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN [J].
EMANUEL, D ;
CUNNINGHAM, I ;
JULESELYSEE, K ;
BROCHSTEIN, JA ;
KERNAN, NA ;
LAVER, J ;
STOVER, D ;
WHITE, DA ;
FELS, A ;
POLSKY, B ;
CASTROMALASPINA, H ;
PEPPARD, JR ;
BARTUS, P ;
HAMMERLING, U ;
OREILLY, RJ .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) :777-782